Growth Metrics

Cme (CME) Equity Income (2016 - 2026)

Cme has reported Equity Income over the past 18 years, most recently at $102.4 million for Q1 2026.

  • Quarterly Equity Income rose 16.1% to $102.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $385.9 million through Mar 2026, up 9.66% year-over-year, with the annual reading at $371.7 million for FY2025, 5.93% up from the prior year.
  • Equity Income was $102.4 million for Q1 2026 at Cme, up from $88.2 million in the prior quarter.
  • Over five years, Equity Income peaked at $102.4 million in Q1 2026 and troughed at $64.0 million in Q4 2022.
  • The 5-year median for Equity Income is $86.4 million (2024), against an average of $83.7 million.
  • Biggest five-year swings in Equity Income: skyrocketed 56.73% in 2022 and later decreased 13.97% in 2023.
  • Tracing CME's Equity Income over 5 years: stood at $64.0 million in 2022, then grew by 4.38% to $66.8 million in 2023, then soared by 36.53% to $91.2 million in 2024, then dropped by 3.29% to $88.2 million in 2025, then rose by 16.1% to $102.4 million in 2026.
  • According to Business Quant data, Equity Income over the past three periods came in at $102.4 million, $88.2 million, and $96.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.